Eli Lilly
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
CEODavid A. Ricks
CEODavid A. Ricks
Employees47,000
Employees47,000
HeadquartersIndianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded1876
Founded1876
Employees47,000
Employees47,000
LLY Key Statistics
Market cap739.66B
Market cap739.66B
Price-Earnings ratio64.67
Price-Earnings ratio64.67
Dividend yield0.72%
Dividend yield0.72%
Average volume3.24M
Average volume3.24M
High today$783.55
High today$783.55
Low today$773.00
Low today$773.00
Open price$780.30
Open price$780.30
Volume1.45M
Volume1.45M
52 Week high$972.53
52 Week high$972.53
52 Week low$677.09
52 Week low$677.09
LLY News
TipRanks 2d
Eli Lilly and Regeneron: Exploring New Frontiers in Obesity TreatmentEli Lilly And Company ((LLY)), Regeneron Pharmaceuticals ((REGN)) announced an update on their ongoing clinical study. Don’t Miss TipRanks’ Half-Year Sale Tak...
TipRanks 5d
Tests Show Eli Lilly’s Weight-Loss Pill Works as Well as InjectionPreliminary test results show that Eli Lilly’s (LLY) daily weight-loss pill, called Orforglipron, is as effective as the company’s injectable GLP-1 drug Zepboun...
TipRanks 6d
Eli Lilly Stock Consolidates in Value TerritoryEli Lilly (LLY) has recently become a core holding in my portfolio, and current market conditions present an attractive opportunity to initiate or expand a posi...
Analyst ratings
83%
of 30 ratingsBuy
83.3%
Hold
10%
Sell
6.7%
More LLY News
Seeking Alpha 7d
Novo Nordisk, Eli Lilly face first major obesity drug rival in China as Innovent gains approval for mazdutideNovo Nordisk (NVO) and Eli Lilly & Co. (NYSE:LLY), the global leaders in obesity medications, are now facing their first major competitor in China. Suzhou-base...
People also own
Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.